RIBB SEC filings, in plain English
Everything Ribbon has filed with the SEC that we hold — 40 filings, newest first, 39 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: On September 2, 2026, Ribbon Acquisition Corp. and target DRC Medicine Ltd. entered into a package of financing agreements with Meteora Select Trading Opportunities Master, LP: an OTC Equity Prepaid Forward Transaction for up to 4,100,000 PubCo shares at the redemption price (initially $10.00 per share), a Subscription Agreement for those shares, a Standby Equity Purchase Agreement (SEPA) for up to $100,000,000 over 36 months at 97% of market price, a $1,212,121 convertible promissory note (issued for $1,000,000, a 17.5% OID), and a Registration Rights Agreement. The SEPA carries a 1.75% commitment fee ($1,750,000), a 19.99% exchange cap, and a 4.9% investor ownership limit; the Note bears 18% default interest, a 7% payment premium, converts at 95% of the lowest 5-day VWAP, and requires 33% of future financing proceeds to be applied to repayment. Certain PubCo shareholders will deposit 9.9% of outstanding post-closing shares into escrow, transferring to Meteora upon a Note default. The S-4 registration statement was declared effective and the definitive proxy statement/prospectus was filed on August 24, 2026. Why it matters: This filing discloses the full financing structure supporting the DRC Medicine business combination, revealing significant dilution risk from the SEPA's $100M capacity, the Note's variable-rate conversion at a 5% discount to VWAP, and the forward purchase mechanics that draw on trust funds — all critical for estimating post-close share count and trust value erosion. The escrow of 9.9% of PubCo shares as Note collateral and the 33% proceeds-sweep requirement impose constraints on the combined company's capital flexibility that investors should weigh ahead of the shareholder vote.
What changed: Ribbon Acquisition Corp. filed an 8-K on September 3, 2026, incorporating by reference the terms of five agreements dated September 2, 2026: a Standby Equity Purchase Agreement, Convertible Promissory Note, Registration Rights Agreement, Forward Purchase Agreement, and Subscription Agreement with Meteora Select Trading Opportunities Master, LP. Why it matters: These financing arrangements provide capital support for the proposed business combination with DRC Medicine Ltd., which is critical given the redemption risk and the January 16, 2027 deadline for Ribbon's trust value maintenance.
What changed: Form 8-K Current Report under Section 13 or 15(d) of the Securities Exchange Act of 1934. The registrant reported that an aggregate $125,000 Extension Payment was deposited into the trust account on August 11, 2026. According to the filed 8-K, this deposit extends the business combination timeline by one month, moving the immediate deadline from August 15, 2026 to September 15, 2026. The filing is signed by Chief Executive Officer Angshuman (Bubai) Ghosh. Why it matters: Public shareholders now face a revised short-term liquidation trigger of September 15, 2026 rather than August 15, 2026. The $125,000 trust infusion confirms ongoing sponsor funding to maintain listing compliance and delay dissolution, but the filing discloses no target pipeline, commercial operations, customer contracts, revenue projections, market positioning, redemption price recalculations, or changes in sponsor conduct. It functions purely as a mechanical preservation of the trust vehicle to sustain the statutory window for a future merger.
What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2026, filed by Ribbon Acquisition Corporation, a blank-check SPAC. Trust account cash fell from $51,948,314 to $38,410,540 due to $14,937,326 in redemptions and $750,000 in extension deposits; a $902,938 promissory note was issued to sponsor affiliate; the company reported a net income of $233,154 for the six months compared to $507,153 in the prior year; working capital deficit increased to $1,797,571; an extension meeting was held, extending the deadline to January 16, 2027, with $875,000 in monthly extension deposits made through July 15, 2026, and a subsequent $125,000 deposit on July 14, 2026, extending the deadline to August 15, 2026. No material changes to the business combination agreement with DRC Medicine were noted. Why it matters: The trust erosion from redemptions and rising liabilities highlight the time pressure to close the DRC Medicine deal. The cash burn and negative working capital underscore going concern risk if the extension is exhausted or the deal fails. The $600,000 promissory note and monthly extension payments reflect sponsor support, but the trust balance is shrinking. The extension meeting and continued payments show the sponsor is buying time, but the clock is ticking toward January 2027.
trust account, combination deadline, going-concern doubt +1nothing moved · 4 with no prior record of ours
- Trust account
- $51.9M · unchanged
- Combination deadline
- 2027-01-16 · unchanged
- Going-concern doubt
- stated · unchanged
- Redeemable shares
- 3.56M · unchanged
The clause …“As of June 30, 2026 and December 31, 2025, the Company had $ 38,410,540 and $ 51,948,314 , respectively, in cash held in the Trust Account. Offering Costs Associated with the IPO Offering costs consist principally of professional and”…
The clause …“must consummate its initial business combination from January 16, 2026 to January 16, 2027. The Company may seek to fund its working capital needs through additional borrowings from its Sponsor or its affiliates, including the”…
The clause “14-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the mandatory liquidation, should a business combination not occur, and potential subsequent dissolution,”…
The clause “002 Class A ordinary shares, $ 0.0001 par value, 450,000,000 shares authorized, 3,563,133 shares subject to possible redemption as of June 30, 2026 35,062,690 49,736,459 Commitment and contingencies (Note 6) Shareholder’s Deficit Class A”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Form 8-K Current Report filed by Ribbon Acquisition Corp. under Item 8.01 (Other Events). As disclosed in the filing and signed by Chief Executive Officer Angshuman (Bubai) Ghosh, Ribbon Acquisition Corp. deposited an aggregate of $125,000 into the trust account. This payment functionally extends the period to consummate an initial business combination by one month, shifting the deadline from July 15, 2026 to August 15, 2026. Why it matters: The $125,000 deposit permanently reduces the gross trust corpus, directly lowering the per-share residual value available to public shareholders at redemption or merger closing. The updated date establishes the next operative window for shareholder conversion/redemption rights prior to any mandatory dissolution or liquidation triggers. The filing contains no additional substance regarding corporate operations, customer bases, revenue streams, market positioning, technology developments, commercial partnerships, ongoing litigation, or personnel changes beyond the officer execution block.
What changed: A Form 8-K Current Report filed by Ribbon Acquisition Corp. under Item 8.01 disclosing a trust account extension payment and resolution of Nasdaq listing compliance. According to the filing, Ribbon Acquisition Corp. deposited an aggregate of $125,000 (the “Extension Payment”) into its trust account for public shareholders, which extends the period to consummate an initial business combination by one month from June 15, 2026 to July 15, 2026. The company further states that, per a letter dated June 9, 2026, from the Listing Qualifications Department of The Nasdaq Stock Market LLC, it regained compliance with Nasdaq Listing Rule 5250(f) following payment of a past due fee balance. This formally resolves the non-compliance matter previously outlined in the registrant’s June 5, 2026 8-K filing. The report was executed by Chief Executive Officer Angshuman (Bubai) Ghosh. Why it matters: The $125,000 contribution materially resets the SPAC’s redemption and liquidation calendar, preserving the trust capital and extending shareholder decision windows through July 15, 2026 rather than triggering an immediate default event. By confirming Nasdaq Listing Rule 5250(f) compliance, the filing eliminates an active delisting overhang that carried imminent risk of suspending trades for Class A Ordinary Shares (RIBB), Units (RIBBU), and Rights (RIBBR). Investors consequently face uninterrupted exchange access and retained redemption rights through the revised deadline.
What changed: Form 8-K Current Report filed under Item 8.01 Other Events announcing a trust account extension payment. According to the registrant, an aggregate of $125,000 was deposited into the trust account, extending the period to consummate an initial business combination by one month from May 15, 2026 to June 15, 2026. Why it matters: Mechanically, the payment suspends the liquidation trigger and shifts the redemption window forward by 30 days. Chief Executive Officer Angshuman (Bubai) Ghosh signed the report on June 8, 2026, authorizing the deposit. The filing contains no additional substantive updates: the company makes no claims regarding customers, revenue, market size, technology, strategic partnerships, litigation, or personnel changes, and only reiterates that Class A Ordinary Shares carry a par value of $0.0001 per share.
What changed: SEC Form 8-K Current Report disclosing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard (Item 3.01). On June 4, 2026, Nasdaq’s Listing Qualifications Department issued a staff determination letter notifying Ribbon Acquisition Corp. that it will delist the Company’s securities for failing to pay fees required under Nasdaq Listing Rule 5250(f). According to the Notice, the past-due fee balance currently totals $75,000. The Company plans to appeal to a Hearings Panel, with a hearing request deadline of 4:00 p.m. Eastern Time on June 11, 2026, and a hearing fee of $20,000. An automatic stay of suspension applies pending the Panel's ruling. The filing does not modify or pause the existing January 16, 2027 merger deadline. Why it matters: Loss of the NASDAQ listing severs the standardized public trading channel required for orderly share redemptions and proxy solicitation, increasing the operational friction around trust distribution if the deal fails or extends. Chief Executive Officer Angshuman (Bubai) Ghosh confirmed the Company is engaged in discussions with Nasdaq to promptly resolve the outstanding fees but disclaimed any assurance of maintaining the listing. The registrant operates as a Cayman Islands blank check company with its principal executive office in Tokyo, Japan, suggesting potential cross-jurisdictional administrative or liquidity pressures underlying the exchange fee default. No data on business combinations, target pipelines, revenue, or trust account balances is provided.
What changed: Quarterly report on Form 10-Q for the quarter ended March 31, 2026, filed by Ribbon Acquisition Corp. (RIBB), a SPAC that has announced a business combination with DRC Medicine Ltd. Trust account balance decreased from $51,948,314 to $37,716,530 due to redemption of 1,436,867 public shares at ~$10.40 per share in January 2026. Deadline extended from January 16, 2026 to January 16, 2027, with monthly extension payments of $125,000. Company issued a $600,000 non-interest-bearing promissory note to a shareholder of the sponsor. Working capital deficit of $1,008,960. Net income of $252,755 from interest income. Going concern disclosure updated. No material changes to business combination agreement terms with DRC Medicine. Why it matters: The filing reveals significant redemptions reducing trust assets, ongoing extension payments that deplete funds, and a going concern warning if the business combination fails. The promissory note indicates sponsor support. Investors evaluating redemption risk or deal completion timeline need this updated financial picture.
What changed vs 2025-11-14trust $51.5M → $51.9M +1%deadline 2026-01-16 → 2027-01-16shares 5.00M → 3.56M -29%trust account, combination deadline, redeemable shares +13 moved · 1 with no prior record of ours
- Trust account
- $51.5M$51.9M
- Combination deadline
- 2026-01-162027-01-16
- Redeemable shares
- 5.00M3.56M
- Going-concern doubt
- stated · unchanged
SpacBrain reads this as $487,004 was added to the trust between the two filings.
The clause …“As of March 31, 2026 and December 31, 2025, the Company had $ 37,716,530 and $ 51,948,314 , respectively, in cash held in the Trust Account. Offering Costs Associated with the IPO Offering costs consist principally of professional and”…
SpacBrain reads this as 365 days later than the previous record.
The clause …“must consummate its initial business combination from January 16, 2026 to January 16, 2027. The Company may seek to fund its working capital needs through additional borrowings from its Sponsor or its affiliates, including the”…
SpacBrain reads this as 1,436,867 shares are no longer redeemable.
The clause “002 Class A ordinary shares, $ 0.0001 par value, 450,000,000 shares authorized, 3,563,133 shares subject to possible redemption as of March 31, 2026 35,062,690 49,736,459 Commitment and contingencies (Note 6) Shareholder s Deficit Class A”…
The clause “014-15, Disclosures of Uncertainties about an Entity s Ability to Continue as a Going Concern, management has determined that the mandatory liquidation, should a business combination not occur, and potential subsequent dissolution, raises”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Joint Filing Agreement attached to a Schedule 13G beneficial ownership report. The document formalizes an agreement under Rule 13d-1(k) for Westchester Capital Management, LLC, Westchester Capital Partners, LLC, Virtus Investment Advisers, LLC, and The Merger Fund to jointly file a Schedule 13G regarding their holdings in Ribbon Acquisition Corporation’s Ordinary Shares. Executed on May 15, 2026 by CaSaundra Wu (Chief Compliance Officer), Chetram Persaud (Chief Compliance Officer), and Daphne Chisolm (Vice President, Counsel and Assistant Secretary), the text contains no share quantities, acquisition prices, or ownership percentages. Consequently, it introduces no changes to redemption deadlines, trust value mechanics, extension triggers, or sponsor conduct. Why it matters: This exhibit confirms that four institutional vehicles are maintaining active SEC reporting obligations for RIBB during the announced-deal phase. Because the primary Schedule 13G data is omitted from this attachment, the filing does not shift the redemption calendar, adjust trust distributions, or signal lock-up behavior. The joint-filing arrangement reflects coordinated compliance among affiliated managers, which investors watch when assessing potential blockholder alignment or upcoming position disclosures. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, personnel changes, or litigation.
What changed: Routine compliance exhibit—a Schedule 13G/A beneficial ownership report. Polar Asset Management Partners Inc. submitted this amended filing to update public records of its security positions. The provided text contains only the filing designation, the SEC accession number, and the holder’s corporate name. It contains no disclosures, proposals, or updates regarding Ribbon’s redemption calendar, trust distribution mechanics, extension votes, business combination timeline, or sponsor conduct. Why it matters: The document attributes no claims to Polar Asset Management Partners Inc. or any other party regarding Ribbon’s operations, financial performance, customer base, market positioning, technology, partnerships, litigation, or leadership. Because the excerpt contains zero commercial, strategic, or structural assertions, it does not modify shareholder redemption rights, alter the deal progression framework, or impact sponsor accountability measures.
What changed: A routine compliance exhibit—specifically, a Schedule 13G beneficial ownership report—filed to register equity holdings in Ribbon (RIBB) by Hudson Bay Capital Management LP and Sander Gerber. The provided filing text contains no disclosures regarding redemption deadline adjustments, trust value per share revisions, extension voting procedures, merger or business combination progress, or sponsor conduct. The only quantifiable identifiers present are the SEC submission tag 0001393825-26-000039 and the filing date 2026-05-12. Why it matters: Although Schedule 13G filings typically mark the crossing of a five-percent beneficial ownership threshold or indicate coordinated investment activity, this excerpt omits share counts, percentage of outstanding class, acquisition purpose language, and amendment indicators. Consequently, it supplies zero evidence of capital deployment shifts, redemption floor mechanics, or transaction timeline modifications. Because the document advances no claims regarding customer contracts, revenue milestones, total addressable market sizing, technology development, partnership formations, litigation exposure, or executive personnel changes, there are no attributed statements to weigh against existing deal parameters. Investors monitoring the SPAC lifecycle must treat this as a baseline regulatory disclosure rather than a catalyst for near-term redemption actions or closing events.
What changed: Amendment No. 1 to Ribbon Acquisition Corporation's Form 10-K for the fiscal year ended December 31, 2025, originally filed March 31, 2026. It is filed solely to add the company's Clawback Policy as Exhibit 97.1. No other change is made, and the amendment expressly does not reflect events after the original filing or modify any disclosure. The cover page states that 4,793,446 ordinary shares were issued and outstanding as of March 31, 2026. Why it matters: This is an exhibit-only housekeeping filing with no economic content: no financial statement, trust balance, deadline or transaction disclosure is amended or updated. Its only significance is compliance, since exchange rules require a listed issuer's annual report to include the compensation recovery policy, and Ribbon has now supplied it. Investors should look to the original March 31, 2026 annual report for anything that bears on trust value or the business-combination timetable, because nothing here changes it.
What changed: A Form 8-K Current Report filed by Ribbon Acquisition Corp. to officially record a monthly trust account contribution that activates a pre-approved extension of the business combination deadline. According to Item 8.01, which was signed by Chief Executive Officer Angshuman (Bubai) Ghosh on behalf of the registrant, an aggregate of $125,000 was deposited into the company’s trust account on April 14, 2026. The filing states this deposit funds a one-month extension of the deadline to consummate the initial business combination, consistent with the Extension Amendment and Trust Amendment previously approved by shareholders. Why it matters: This filing confirms the continued activation of the monthly extension mechanism, pushing the redemption/liquidation trigger forward by one month without forcing a capital call or public offering at this stage. Investors monitoring the extension cadence should track future 8-Ks for subsequent $125,000 deposits or potential shifts in trustee arrangements. The filing discloses no information regarding deal progress, customer metrics, revenue, market positioning, technology partnerships, or litigation, and reports no changes to sponsor conduct or board composition beyond the standard executive attestation of the extension deposit.
What changed: Form 8-K Current Report (Item 8.01 Other Events) announcing the adjournment of Ribbon Acquisition Corp.'s Extraordinary General Meeting of Shareholders. Per the Company's filing executed by Chief Executive Officer Angshuman (Bubai) Ghosh, the Extraordinary General Meeting originally slated for April 13, 2026 at 10:00 a.m. Eastern Time was adjourned on April 13, 2026. The revised date is Monday, September 14, 2026 at 10:00 a.m. Eastern Time. The record date for entitled voters remains February 18, 2026, with pre-submitted proxies auto-carried forward unless revoked. This procedural shift extends the timeline for any pending merger approvals or trust liquidation votes into Q3 2026 while remaining within the standard trust survival window, without altering the underlying redemption mechanics or sponsor equity forfeitures. Why it matters: Shareholders should update their liquidity and redemption calendars, as capital return or conversion events are deferred by roughly five months. Because the record date was fixed at February 18, 2026, investors acquiring shares post-cutoff will not participate in this specific voting cycle, effectively locking out later-market participants from the associated redemption rights. Beyond this administrative postponement and the executive signature line, the filing contains no substantive claims regarding target customers, revenue streams, market size parameters, operational strategy, proprietary technology, partnership frameworks, active litigation, or personnel transitions. The document functions strictly as a logistical notice that management requires additional proxy-solicitation time rather than forcing an accelerated close, preserving the current capital structure and deferring ultimate disposition until the September session concludes.
What changed: Annual Report on Form 10-K for fiscal year 2025, including audited financial statements and management discussion, for a blank-check company that has announced a business combination. Filing discloses the Business Combination Agreement with DRC Medicine Inc. (signed June 30, 2025), a shareholder-approved extension of the combination deadline to January 16, 2027, and a subsequent redemption of 1,436,867 Class A shares (~$14.9 million at ~$10.40 per share) on January 9, 2026. The trust account balance fell accordingly. The report also notes a working capital deficit, a going concern qualification, and adoption of new segment reporting standard. Why it matters: Investors tracking redemption deadlines and trust value need to note the redemption event (30% of public shares redeemed) and the extended deadline. The trust per-share value after redemptions is approximately $10.40, but the trust balance is now reduced. The filing confirms the deal is progressing but includes risk factors about completing the business combination. The going concern warning indicates liquidity risk if the deal fails.
trust account, combination deadline, redeemable shares +2nothing moved · 5 with no prior record of ours
- Trust account
- not previously extracted$51.9M
- Combination deadline
- not previously extracted2027-01-16
- Redeemable shares
- not previously extracted5.00M
- Going-concern doubt
- stated · unchanged
- Mandate language
- we intend to focus our search for an initial business combin… · unchanged
The clause …“Trust Account As of December 31, 2025 and December 31, 2024, the Company had $ 51,948,314 and nil , respectively, in cash held in the Trust Account. Offering Costs Associated with the IPO Offering costs consist principally of”…
The clause …“unable to raise additional funds to alleviate liquidity needs and complete a business combination by January 16, 2027 then the Company will cease all operations except for the purpose of liquidating. The liquidity condition and date”…
The clause “967 Class A ordinary shares, $ 0.0001 par value, 450,000,000 shares authorized, 5,000,000 shares subject to possible redemption as of December 31, 2025 49,736,459 - Commitment and contingencies (Note 6) Shareholder s (Deficit) Equity”…
The clause …“of a Business Combination. In connection with the Company s assessment of going concern considerations in accordance with Financial Accounting Standard Board s Accounting Standards Update ( ASU ) 2014-15, Disclosures of”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Form 8-K current report (Items 8.01 Other Events and 9.01 Exhibits) documenting a trust account deposit and accompanying XBRL exhibits. Per the company’s filing, Ribbon Acquisition Corp. deposited $125,000 into its trust account on March 17, 2026, securing a one-month extension of the deadline to consummate an initial business combination, executed pursuant to shareholder-approved Extension and Trust Amendments. Why it matters: The funding extends the sponsor’s timeline without triggering automatic liquidation or early redemptions, preserving the trust corpus against premature dissolution. As stated in the report, the payment was made 'for the benefit of its public shareholders' and was attested by Chief Executive Officer Angshuman (Bubai) Ghosh from the registrant’s Tokyo address. Because the disclosure solely records the mechanical extension deposit, it attributes zero new claims regarding customers, revenue, market size, technology, partnerships, or litigation to management, the board, or target advisors. For investors tracking the redemption calendar and trust mechanics, this confirms iterative sponsor cash contributions rather than dilutive financing events, but the absence of combination-specific disclosures signals no imminent shareholder vote. Market participants should monitor for subsequent 8-K filings confirming each monthly funding tranche and review the underlying extension amendments for any adjustments to termination rights, redemption pricing, or sponsor lock-up terms.
What changed: Form 8-K Current Report under Item 8.01 (Other Events) announcing the adjournment of an Extraordinary General Meeting of Shareholders. The Company announced that the Extraordinary General Meeting originally scheduled for March 16, 2026, at 10:00 a.m. Eastern Time has been adjourned to allow additional time to solicit proxies regarding the merger proposals. Shareholders of record as of the close of business on February 18, 2026 remain eligible to vote, and proxies previously submitted will be voted at the adjourned meeting unless properly revoked. The Company will announce the new date and time once determined. Why it matters: This adjournment alters the immediate merger timeline by pausing the shareholder vote to avoid a failed approval threshold that could trigger immediate dissolution and cash redemptions. While the statutory deal completion deadline remains January 16, 2027, the postponement indicates that management requires additional days to gather sufficient voting support before proceeding. Chief Executive Officer Angshuman (Bubai) Ghosh executed the filing, confirming that the February 18, 2026 record date stands unchanged and existing proxies carry forward, effectively extending the active voting window indefinitely until a rescheduled date is publicly set.
What changed: Form 8-K Current Report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, constituting a routine compliance exhibit under Item 8.01 Other Events. Ribbon Acquisition Corp. announced that its Extraordinary General Meeting of Shareholders, originally scheduled for March 16, 2026, was adjourned on that same day to April 13, 2026, at 10:00 a.m. Eastern Time. The adjournment provides additional time to solicit proxies regarding the proposed business combination and related proposals. The record date for voting eligibility is February 18, 2026. Chief Executive Officer Angshuman (Bubai) Ghosh executed the filing, confirming that proxies previously submitted will be tallied at the rescheduled meeting unless properly revoked. Why it matters: Delaying the shareholder vote postpones the formal approval milestone necessary to close the merger, keeping redemption windows and trust liquidation timelines in suspension. Advancing the meeting to April 13, 2026 without a simultaneous extension declaration or revised trust funding terms introduces procedural uncertainty for investors tracking deal momentum. The sponsor's explicit need for extra solicitation time highlights ongoing efforts to secure voting thresholds ahead of the adjourned session, requiring investors to monitor subsequent proxy tabulations before making final disposition decisions.
What changed: A Form 8-K current report (Item 8.01 Other Events) filed by Ribbon Acquisition Corp. announcing corporate governance scheduling adjustments. Ribbon Acquisition Corp. announced that the Extraordinary General Meeting of Shareholders, originally scheduled for Thursday, March 12, 2026, at 10:00 a.m. Eastern Time, was adjourned to Monday, March 16, 2026, at 10:00 a.m. Eastern Time. The filing notes the adjournment occurred to allow additional time to solicit proxies regarding the proposals detailed in the meeting notice and accompanying proxy statement. The record date for determining shareholders entitled to vote remains the close of business on February 18, 2026, and all proxies previously submitted will be voted at the adjourned meeting unless properly revoked. Why it matters: The filing directly updates the special meeting calendar, pushing the shareholder vote—and any associated redemption or merger approval deadlines—four days later to March 16, 2026. According to Chief Executive Officer Angshuman (Bubai) Ghosh, the delay is intended solely to extend the proxy solicitation period, indicating a continuation of the business combination process rather than a termination or regulatory halt. While the underlying SPAC dissolution deadline of January 16, 2027, and the Trust Account valuation remain unaffected, the extension temporarily prolongs the uncertainty period for public stockholders weighing redemption elections versus holding positions through the rescheduled vote. The document contains no additional commercial disclosures, financial projections, customer metrics, litigation updates, or personnel changes beyond the administrative scheduling notice and executive signature.
What changed: A Form 8-K Current Report filed under Item 8.01 (Other Events) announcing the adjournment of an Extraordinary General Meeting of Shareholders. Ribbon Acquisition Corp. announced that its Extraordinary General Meeting, originally scheduled for Thursday, March 12, 2026 at 10:00 a.m. Eastern Time, will be adjourned to allow additional time to solicit proxies regarding proposals outlined in a prior notice of meeting and accompanying proxy statement. The company will publicize the new date once finalized. Shareholders of record as of February 18, 2026 retain voting rights, and all previously submitted proxies remain valid unless formally revoked. The report was authored and signed by Chief Executive Officer Angshuman (Bubai) Ghosh on March 11, 2026. Why it matters: In SPAC structures, adjourning a shareholder meeting almost invariably signals that management or the sponsor requires additional shareholder approval to advance a deSPAC transaction, extend the trust termination window, or amend governing documents. This procedural delay keeps redemption windows active and defers capital deployment or return, directly impacting timing relative to the stated January 16, 2027 liquidation horizon. The filing discloses no revenue, customer concentrations, technology roadmap, partnership terms, or litigation. For portfolio managers monitoring trust value and exit mechanics, the key takeaway is timeline extension and proxy dependency; investors should await the supplemental filing listing the rescheduled date and specific ballot measures to evaluate whether the sponsor intends to pursue an extension, amend redemption terms, or accelerate a merger vote before the termination deadline expires.
What changed: A Form 8-K current report disclosing the entry into a material definitive agreement: an unsecured promissory note. According to Item 1.01 and the attached Exhibit 10.1, Ribbon Acquisition Corp. issued a promissory note with a principal amount of $600,000 to Ribbon Investment Company Ltd, identified as a shareholder of the sponsor. As stated in section 12 of the document, the payee expressly waives any claim against the funds held in the company’s IPO trust account and agrees not to seek repayment from those trust funds. If the company fails to consummate an initial business combination, section 12 further provides that repayment will come solely from non-trust amounts, if any, and any unpaid principal and accrued interest shall be forgiven. The note bears no interest, becomes due promptly upon closing a business combination, and allows prepayment without penalty. Standard default triggers include failure to pay within five (5) business days, voluntary liquidation proceedings, or involuntary bankruptcy orders remaining unstayed for 60 consecutive days. Chief Executive Officer Angshuman (Bubai) Ghosh executed the instrument for both parties on March 7, 2026, and designated New York courts for exclusive jurisdiction. Why it matters: This filing materially alters the liability profile surrounding the sponsor while preserving trust account integrity. By contractually subordinating the $600,000 obligation to third-party creditors and completely shielding the trust account, the payee ensures that neither early redemptions nor a potential liquidation would require drawing down the per-share trust balances. Because payment is mechanically triggered only upon business combination closings, the instrument functions as deferred sponsor financing that avoids immediate cash demands and does not accelerate the January 16, 2027 termination deadline. Beyond these structural mechanics, the document contains no commercial forecasts, customer disclosures, revenue projections, technology roadmaps, partnership agreements, or litigation claims. The filing merely establishes the contractual terms governing this specific affiliate advance until a target acquisition closes.
What changed: Definitive Proxy Statement filed by Ribbon Acquisition Corp. to solicit shareholder votes at a Special Meeting on March 12, 2026 to approve Amendment No. 2 to the Investment Management Trust Agreement and an Adjournment Proposal. The Board proposes revising the monthly contribution required for each one-month extension from a fixed US$125,000 to the lesser of US$50,000 or US$0.033 per then-outstanding public share, while keeping the January 16, 2027 termination date intact. According to the filing, the Trust Account held approximately US$37,385,608.09 as of February 20, 2026 across 3,563,133 public shares, producing an estimated per-share redemption price of approximately US$10.49. Public shareholders may exercise redemption rights by tendering shares to Odyssey Transfer and Trust Company by 5:00 p.m. ET on March 10, 2026. The Company also discloses outstanding unsecured working capital loans from the Sponsor and affiliates aggregating to approximately US$500,000. Why it matters: If shareholders reject the amendment, the Company warns it may be forced to liquidate because the Sponsor 'has advised the Company that it does not intend to fund Monthly Contributions in excess of US$50,000 per month,' meaning the prior US$125,000 threshold cannot be met. A lower monthly deposit slows trust accretion, which the Board acknowledges could reduce the eventual per-share redemption amount relative to the original extension framework. On deal progress, the Board confirms a Business Combination Agreement was signed on June 30, 2025 with DRC Medicine Ltd., Pubco, and Merger Sub, but management states additional time is necessary to complete SEC review and satisfy customary closing conditions. Regarding sponsor conduct and conflicts, management discloses the Sponsor paid US$0.0087 per share for 1,250,000 Founder Shares (US$25,000 total) and US$10.00 per unit for 220,000 Private Placement Units (US$2,200,000 total). Based on forward-looking projections outlined by the Board, those Founder Shares could reach a value of approximately US$12.5 million at transaction close, creating a structural incentive for insiders to pursue and close a business combination even if public shareholders receive less favorable terms.
trust account, combination deadlinenothing moved · 2 with no prior record of ours
- Trust account
- not previously extracted$37.4M
- Combination deadline
- 2027-01-16 · unchanged
The clause “Termination Date or amend the Charter. As of February 20, 2026, approximately US$37,385,608.09 was held in the Trust Account. Based on such amount and 3,563,133 public shares outstanding as of such date, the estimated per-share redemption”…
The clause …“its initial business combination. If we are unable to complete our initial business combination by January 16, 2027 (the “Termination Date”), and any applicable regulatory review extends beyond such timeframe or”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: A Form 8-K Current Report filed under Item 8.01 ('Other Events') that discloses administrative cash deposits made into Ribbon Acquisition Corp.'s trust account to secure monthly extensions for the company's business combination deadline. Chief Executive Officer Angshuman (Bubai) Ghosh reported that an aggregate $250,000 has been deposited into the trust account for the benefit of public shareholders. The filing details that $125,000 was deposited in January 2026 to fund a one-month extension of the deadline to consummate the initial business combination, and an additional $125,000 was deposited in February 2026 to fund another one-month extension. Both payments were executed pursuant to Extension and Trust Amendments previously approved by the company's shareholders. The registrant's principal executive offices remain located at Central Park Tower LaTour Shinjuku, Room 3001, Tokyo, Japan, and the entity is incorporated in the Cayman Islands. Why it matters: The filing mechanically pushes the deal completion window forward by two consecutive months without requiring a fresh shareholder vote, as the extension fees were pre-authorized. For investors monitoring redemption windows, these cash infusions demonstrate active sponsor participation in maintaining the trust balance through pre-approved paid extensions, signaling continued search activity but also extended execution risk. No new targets, customer contracts, revenue figures, partnership announcements, litigation matters, or strategic pivots are disclosed; the submission serves strictly as a compliance update tracking extension funding and timeline slippage.
What changed: A routine Schedule 13G beneficial ownership compliance exhibit identifying Rivernorth Capital Management, LLC as the reporting holder. The filing text contains no disclosures regarding Ribbon’s redemption deadline, trust value per share, extension status, merger deal progress, or sponsor conduct. No share counts, percentages, or dollar amounts are reported in the provided excerpt. Why it matters: Per the document itself, this is a standard regulatory filing solely intended to record equity holdings. Because it attributes no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel to any party, and introduces no operational or financial data, it does not affect investor tracking of SPAC mechanics or corporate fundamentals.
What changed: Preliminary Proxy Statement (Schedule 14A) soliciting shareholder votes at an Extraordinary General Meeting on March 12, 2026, specifically regarding a proposed amendment to the Investment Management Trust Agreement to revise the maximum monthly extension contribution to $50,000, alongside an adjournment proposal. According to the filing, approval of the Trust Amendment would revise the monthly extension contribution from the previously disclosed fixed amount of US$125,000 down to a maximum of US$50,000 per month. The Sponsor (Ribbon Investment Company Ltd.) has advised the Company that it 'does not intend to fund Monthly Contributions in excess of US$50,000 per month,' meaning failure to amend could halt further extensions if actual requirements exceed that cap. The Company states that public shareholders retain full redemption rights exercisable up to two business days before the Special Meeting, with the per-share payout tied directly to the Trust Account balance (currently reported as 'approximately US$[ ]') divided by outstanding public shares. The Board of Directors confirmed the Termination Date remains unchanged at January 16, 2027. Voting for the Trust Amendment requires an affirmative vote of at least sixty-five percent (65%) of the Company’s issued and outstanding ordinary shares, voting together as a single class. The filing also discloses outstanding unsecured working capital loans from the Sponsor and its affiliates in an aggregate principal amount of 'approximately US$[ ]', structured as non-interest-bearing loans repayable only upon consummation of a business combination or upon liquidation, though no funds from the Trust Account would be used to repay them in a liquidation scenario. Why it matters: This proxy materially recalibrates the economic calculus for public shareholders weighing redemption versus extension. The Board of Directors stated it needs additional time to navigate SEC review of the pending business combination with DRC Medicine Ltd., signed June 30, 2025, which contemplates a share exchange, domestication to Delaware, and merger. According to the filing, because the Sponsor holds 1,250,000 Founder Shares purchased for $25,000 in the aggregate ($0.0087 or $0.008 per share) and 220,000 Private Placement Units at $10.00 per unit for an aggregate purchase price of $2,200,000—none of which carry redemption rights—the Board and Sponsor face total equity loss if the SPAC liquidates, creating a structural incentive to approve extensions and close the transaction even if public shareholders might prefer liquidation. The Company cautioned that reducing the monthly contribution to $50,000 means each extension adds less incremental value to the trust, which could result in a lower per-share redemption amount in a liquidation compared to the previous $125,000 monthly framework. The filing further identifies regulatory and operational risks, noting potential CFIUS scrutiny for U.S. targets due to the Sponsor’s non-U.S. status, uncertainty around the 1 percent stock repurchase excise tax under the Inflation Reduction Act, and the possibility that the Company may liquidate trust holdings into cash to avoid being classified as an unregistered investment company under the Investment Company Act of 1940, which would halt interest accrual and reduce future redemption values. The Board recommended voting 'FOR' both proposals, while proxy solicitor Advantage Proxy is compensated a customary fee of $8,500 plus expenses.
What changed: A routine compliance exhibit—a Limited Power of Attorney attached to a Schedule 13G/A filing—authorizing designated Mizuho executives to execute, amend, and submit required SEC reports on behalf of their respective entities. The filing reports no alterations to redemption deadlines, trust value per share, extension mechanisms, deal progress, or sponsor conduct. Per the undersigned (Mizuho Financial Group, Inc., Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC) and signed by Hidekatsu Take and Adam Hopkins, the only operational update is the formal delegation of signing authority to Takahiro Katsura, Managing Director, Head of Global Branches & Subsidiaries Coordination Office, Global Corporate Function Coordination Department, to complete, restate, supplement, and timely file Forms 13G and related documents under Sections 13(d) and 13(g) of the Exchange Act. Why it matters: Because the document contains no claims regarding Ribbon’s customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel, and establishes no adjustments to trust account mechanics, shareholder redemption windows, or Merger Co transaction timelines, it carries no direct bearing on capital allocation, trust preservation, or deal execution risk. Its sole function, as acknowledged by the signatories, is to satisfy ongoing Exchange Act compliance through internal corporate authorization for periodic beneficial ownership reporting.
What changed: A Joint Filing Agreement submitted alongside a Schedule 13G, executed by Feis Equities LLC and Lawrence M. Feis pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934. The document reports no changes to redemption deadlines, trust per-share value, extension status, business combination progress, or sponsor conduct. The undersigned parties simply agree that the Schedule 13G statement dated February 11, 2026, and any subsequent amendments filed on Schedule 13D, shall be submitted jointly on behalf of both Feis Equities LLC and Lawrence M. Feis. Why it matters: It administratively confirms the co-filing structure for the Feis entities' combined beneficial ownership reporting of Ribbon Acquisition Corp. Class A ordinary shares, but introduces no new variables, commercial assertions, or structural shifts that would affect the redemption window, trust mechanics, deal timeline, or sponsor behavior. The text contains no additional substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel.
What changed: 8-K filing reporting shareholder approval of an amendment to extend the deadline for consummating a business combination from January 16, 2026 to January 16, 2027, and the filing of the Second Amended and Restated Memorandum and Articles of Association. The deadline for the SPAC to complete its initial business combination was extended by one year, from January 16, 2026 to January 16, 2027, via a shareholder-approved amendment to the company's charter. Why it matters: Without this extension, Ribbon Acquisition Corp. would have been required to liquidate and redeem public shares. The extension provides the SPAC an additional year to close a business combination, directly affecting the redemption deadline and trust distribution timeline. Since the SPAC is in a DEAL_ANNOUNCED status, this extension likely provides time to close the announced transaction.
What changed: Form 8-K Current Report filed by Ribbon Acquisition Corp. on January 27, 2026, reporting that at an extraordinary general meeting held on January 9, 2026, shareholders approved amendments to extend the deadline for completing a business combination from January 16, 2026 to January 16, 2027, and to eliminate the Company's ability to withdraw up to $100,000 of interest earned on the trust account to pay dissolution expenses. The deadline by which the Company must consummate an initial business combination was extended from January 16, 2026 to January 16, 2027. Additionally, the Company's ability to withdraw up to $100,000 of interest earned on the trust account to pay dissolution expenses was eliminated. Why it matters: Investors tracking redemption deadlines now have a new deadline of January 16, 2027, providing an additional year for the SPAC to close a deal. The elimination of the $100,000 interest withdrawal for dissolution expenses slightly reduces potential erosion of trust value. The extension was approved by shareholders, indicating sponsor commitment to continue searching for a target. Trust per-share value remains $10.00 as stated in the context.
What changed: Amendment No. 1 to Form 8-K (8-K/A) filed by Ribbon Acquisition Corp. on January 12, 2026, functioning as the definitive disclosure of final voting outcomes and cash redemption statistics from the Special Meeting of Stockholders held on January 9, 2026. This filing supplements the initial 8-K by appending the exact post-meeting redemption ledger and binding governance amendments. The Company reports that holders of 1,436,867 public Class A ordinary shares exercised redemption rights, receiving an aggregate payout of $14,937,325.92 at a per-share amount of approximately $10.395761. Board-submitted proposals passed with 4,811,942 votes For, 164,735 Against, and 0 Abstentions. Key mechanical alterations include approving an Extension Amendment that moves the business combination deadline from January 16, 2026 to January 16, 2027, authorizing a Trust Agreement amendment that requires a $125,000 monthly deposit into the trust account, and removing the prior charter provision that permitted the Company to withdraw up to US$100,000 of earned interest to pay dissolution expenses. The Company also approved a mandate requiring it to file a new Form 8-K for each subsequent monthly extension payment. Of the 6,470,000 shares outstanding as of the December 9, 2025 record date, 4,976,677 shares (76.92%) constituted a quorum. Beyond these voting, redemption, and governance items, the Company makes no assertions regarding customers, revenue streams, market sizing, competitive strategy, technology development, partnership pipelines, litigation exposure, or executive compensation. Why it matters: For redemption-track investors, this filing formally resets the SPAC’s liquidation timeline to January 16, 2027, eliminating imminent expiration risk and establishing a twelve-month runway for merger execution. The disclosed $14,937,325.92 outflow directly reduces the trust corpus, while the mandatory $125,000 monthly infusion creates a predictable accretion schedule that will partially offset future redemption waves or extension requests. Stripping the $100,000 dissolution expense withdrawal right fortifies the residual trust balance, ensuring fewer encumbrances remain on shareholder funds during any hypothetical wind-down. The explicit obligation to 8-K-file each monthly payment guarantees real-time visibility into trust maintenance costs and remaining liquidity, allowing holders to model exact cash-equivalent thresholds and evaluate whether continued holding aligns with their redemption preferences ahead of the new January 16, 2027 cutoff.
What changed: Form 8-K filed under cover of a DEFA14A, reporting the binding results of Ribbon Acquisition Corp.’s Special Meeting of Stockholders held on January 9, 2026, where security holders ratified governance and trust amendments. According to the company’s filing, the deadline to consummate an initial business combination was extended from January 16, 2026 to January 16, 2027. The Investment Management Trust Agreement, dated January 14, 2025, was amended to require a monthly extension payment of $125,000 deposited into the trust account. The same agreement was further amended to remove the provision permitting the Company to withdraw up to US$100,000 of interest earned on the trust account to pay dissolution expenses, and to mandate a Current Report on Form 8-K for each monthly extension payment. The registrant states that 6,470,000 ordinary shares were issued and outstanding on the December 9, 2025 record date, with 4,976,677 shares (representing 76.92% of outstanding shares) present at the meeting. Proposal 1 received 4,811,942 For votes and 164,735 Against. Proposals 2 and 3 received identical tallies. Proposal 4 received 4,811,941 For, 164,735 Against, and 1 Abstain. Proposal 5 received 4,811,942 For and 164,735 Against. The document is signed by Chief Executive Officer Angshuman (Bubai) Ghosh. Why it matters: This routine compliance exhibit fundamentally alters the SPAC’s capital maintenance mechanics without addressing commercial progress. The removal of the authorization to draw up to US$100,000 of accrued trust interest for dissolution expenses forces all potential wind-down costs onto principal or external capital, while the new $125,000 monthly deposit obligation establishes a fixed carrying cost that reduces net trust growth relative to prior terms. The company’s reported quorum of 4,976,677 shares and consistent 4,811,942-for-vote margins confirm sponsor-aligned proxy consolidation, effectively securing a twelve-month runway through January 16, 2027 subject to Cayman Islands Registrar filing procedures. Because the filing discloses no information regarding target identification, revenue projections, customer contracts, litigation exposure, or board changes, its substantive value lies exclusively in trust covenant restructuring and timeline preservation. Investors modeling liquidation floors should track how the $125,000 monthly erosion interacts with prevailing money-market yields, recognizing that no redemption election data or secondary market sentiment metrics are contained herein.
What changed: This document is a Form 8-K current report disclosing the voting outcomes of a Special Meeting of Stockholders held on January 9, 2026, concerning amendments to the registrant’s Memorandum and Articles of Association and its Investment Management Trust Agreement. Per the filing, security holders approved Proposal 1, extending the deadline to consummate an initial business combination from January 16, 2026, to January 16, 2027. Under Proposal 2, the registrant amended its Investment Management Trust Agreement to require a monthly extension payment of $125,000 to be deposited into the trust account for each monthly extension period. Under Proposal 3, the Company removed a provision that previously permitted withdrawals of up to US$100,000 of interest earned on the trust account to pay dissolution expenses. Under Proposal 4, the filing establishes a mandate that the Company will file a Current Report on Form 8-K for each monthly extension payment made in connection with these amendments. As stated in the report, there were 6,470,000 ordinary shares issued and outstanding entitled to vote as of the December 9, 2025 record date. Of those, 4,976,677 shares constituted a quorum, representing 76.92% of outstanding shares. The final tally recorded 4,811,942 votes For and 164,735 votes Against across all proposals (with one abstention logged for Proposal 4). The submission was signed by Chief Executive Officer Angshuman (Bubai) Ghosh. Why it matters: The approved extension resets the liquidation timeline to January 16, 2027, granting the sponsor twelve additional months to close a merger before trust funds must be distributed or the entity dissolved. Mechanically, the trust fund trajectory shifts: the new $125,000 monthly obligation now flows directly into the trust account rather than depleting it, while eliminating the prior US$100,000 dissolution expense carve-out removes a historical cost-offset mechanism. By contractually binding the Company to file an 8-K for every subsequent monthly deposit, the registrant has instituted a recurring transparency protocol that directly impacts how investors track trust account accretion and calculate redemption floor values leading into the new deadline. Beyond the extension mechanics and governance amendments, the filing contains no disclosures regarding target industry sectors, customer pipelines, projected revenue streams, market capitalization assumptions, proprietary technology, strategic partnerships, active litigation matters, or executive compensation packages.
What changed: Definitive Proxy Statement (DEF 14A) convening a Special Meeting of Stockholders to vote on amendment proposals. The Board proposes extending the initial business combination deadline from January 16, 2026 to January 16, 2027. To facilitate this, the Sponsor (Ribbon Investment Company Ltd.) is expected to make fixed monthly contributions of $125,000 into the Trust Account, which the Board states will be structured as non-interest-bearing, unsecured loans repayable solely upon a completed business combination. The filing removes the prior authorization to withdraw up to US$100,000 of Trust interest for dissolution expenses and mandates filing a Current Report on Form 8-K within four business days of each extension payment. Per the Board, the Trust Account held approximately $51,792,864.57 as of December 15, 2025, yielding an estimated redemption price of approximately $10.4069 per share. Assuming zero redemptions and full Sponsor Contributions through the Extended Date, the Board estimates the redemption price would rise to approximately $10.59 per share. Why it matters: Investors face a binary choice: approve a funding-dependent extension that raises the trust floor to approximately $10.59 but introduces $125,000/month in unsecured debt reducing post-merger proceeds, or reject the extension and trigger liquidation by January 16, 2026 at the current approximate $10.4069 floor. Approval requires an affirmative vote of at least two-thirds (2/3) of voting shares, and both the Charter and Trust Amendments are legally tethered, meaning rejecting one voids the other. The Board notes public shares closed at approximately $10.34 on December 15, 2025, and warns of insufficient liquidity to sell above redemption price. Insiders hold 1,470,000 votes collectively (including 1,250,000 Founder Shares acquired for $25,000 and 220,000 Private Units bought for $2,200,000), creating a conflict where they could profit even if public shareholders suffer losses. Existing $1,000 in working capital loans and potential CFIUS, Investment Company Act, or Inflation Reduction Act excise tax exposures further complicate the path to a viable transaction.
What changed: Preliminary Proxy Statement (PRE 14A) soliciting shareholder votes at a Special Meeting on January 9, 2026 to approve charter and trust amendments for a one-year extension, eliminate dissolution expense withdrawals, mandate monthly 8-K filings for extension payments, and permit meeting adjournment for further proxy solicitation. The Board proposes extending the business combination deadline from January 16, 2026 to January 16, 2027, contingent on a two-thirds (2/3) shareholder vote. Under the proposed structure, Sponsor Ribbon Investment Company Ltd. expects to deposit fixed monthly contributions of $125,000 into the Trust Account, structured as non-interest-bearing, unsecured loans repayable only upon a business combination. Based on a Trust Account balance of approximately $51,633,847.52 as of November 24, 2025, and 4,975,754 public shares outstanding, the estimated per-share redemption price is approximately $10.3771; with contributions through the Extended Date, it is projected to reach approximately $10.59. The filing also proposes removing the provision allowing withdrawals of up to US$100,000 of interest for dissolution expenses and requiring Form 8-K disclosures within four (4) business days of each Sponsor Contribution. Redemptions must be tendered by 5:00 p.m. Eastern Time on January 7, 2026. Why it matters: Board Chairman and CEO Angshuman (Bubai) Ghosh and the directors state the extension is necessary to potentially consummate an initial business combination, though insiders face misaligned incentives: the Sponsor’s 1,250,000 Founder Shares were acquired for $25,000 total ($0.0087 per share) and its 220,000 private units cost $2,200,000, both expiring worthless upon liquidation. The filing discloses outstanding unsecured working-capital loans of $1,000. Risk factors warn that CFIUS review or classification as an unregistered investment company could force liquidation, potentially triggering discretionary cash conversions that halt Trust interest accrual. The Securities and Exchange Commission’s excise tax on stock repurchases may apply to redemptions, payable solely by the Company without accessing the Trust Account. On November 12, 2025, Class A ordinary shares closed at approximately $10.51, though management cautioned that secondary market liquidity remains insufficient to guarantee trades above the redemption floor. Total outstanding ordinary shares numbered 6,470,000 as of September 30, 2025, with the Sponsor and directors collectively controlling voting rights for 1,470,000 shares.
What changed: Quarterly report on Form 10-Q for the period ended September 30, 2025, filed by Ribbon Acquisition Corporation. The 10-Q reports the company's first full quarterly results since its January 2025 IPO. Trust account holds $51,461,310 (no extension yet; deadline January 16, 2026). The company has a working capital deficit of $190,092 and net cash used in operations of $637,983, with management expressing substantial doubt about going concern. On June 30, 2025, the company entered into a Business Combination Agreement with DRC Medicine (AI-powered allergy/infection diagnostic kits). The deal values DRC Medicine at an equity value of $350,000,000, with the aggregate merger consideration to be divided by the redemption price per share. Sponsor conduct: On January 16, 2025, the Sponsor surrendered 187,500 Class B shares for cancellation, leaving 1,250,000 Class B shares outstanding. The promissory note to the Sponsor was repaid. On August 22, 2025, the Sponsor provided a $1,000 interest-free loan. The company also disclosed that RiverNorth Capital Management beneficially owned 6.18% of units as of June 30, 2025. Why it matters: This filing is the first comprehensive financial update since the IPO, providing critical metrics for investors assessing redemption risk and deal viability. The trust value per share is approximately $10.29 (including interest), but the working capital deficit and going concern warning highlight the need for a successful business combination. The detailed terms of the DRC Medicine merger (equity value, consideration mechanics) allow investors to evaluate potential dilution and deal structure. Sponsor share surrender and loan activity provide insight into sponsor alignment. The deadline of January 16, 2026, creates a clear timeline for redemption decisions.
What changed vs 2025-08-13trust $50.9M → $51.5M +1%trust account, combination deadline, going-concern doubt +11 moved · 3 with no prior record of ours
- Trust account
- $50.9M$51.5M
- Combination deadline
- 2026-01-16 · unchanged
- Going-concern doubt
- stated · unchanged
- Redeemable shares
- 5.00M · unchanged
SpacBrain reads this as $525,854 was added to the trust between the two filings.
The clause …“Trust Account As of September 30, 2025 and December 31, 2024, the Company had $ 51,461,310 and nil , respectively, in cash held in the Trust Account. Offering Costs Associated with the IPO Offering costs consist principally of”…
The clause …“of an initial Business Combination. In addition, the Company currently has until January 16, 2026 (unless the Company extends such period by amending its Amended and Restated Memorandum and Articles of Association) to consummate”…
The clause “014-15, Disclosures of Uncertainties about an Entity s Ability to Continue as a Going Concern, management has determined that the mandatory liquidation, should a business combination not occur, and potential subsequent dissolution, raises”…
The clause “967 Class A ordinary shares, $ 0.0001 par value, 450,000,000 shares authorized, 5,000,000 shares subject to possible redemption as of September 30, 2025 48,204,536 - Commitment and contingencies (Note 6) Shareholders Equity Class A”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: Schedule 13G/A amendment, a routine SEC compliance exhibit disclosing changes in beneficial ownership. This amended report was filed by Rivernorth Capital Management, LLC. The provided excerpt does not disclose adjusted share totals, percentage positions, or transaction dates. It contains no modifications to Ribbon’s merger timeline, redemption threshold, trust value per share ($10), January 16, 2027 deadline, extension procedures, or sponsor conduct protocols. Why it matters: Filed by Rivernorth Capital Management, LLC, this submission serves only as a periodic institutional ownership disclosure. It does not alter the announced deal mechanics, liquidate trust assets ahead of schedule, trigger an extension vote, or indicate any sponsor-side commitment. The excerpt makes no assertions about Ribbon’s customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Accordingly, it does not shift shareholder redemption calculus or affect pending business combination progress.
What changed: Schedule 13G beneficial ownership report (routine compliance exhibit). Filed 2025-08-14, the document identifies Rivernorth Capital Management, LLC as the reporting entity. The provided excerpt contains no share quantities, acquisition dates, or pricing data. It does not reference redemption windows, trust per-share values, extension proposals, merger execution status, or sponsor conduct. Why it matters: As a standard equity disclosure, this filing does not modify the RIBB deal timeline or shareholder redemption mechanics. Because the excerpt lacks numerical holdings or strategic commentary, it conveys no actionable changes to the announced transaction, trust preservation, or SPAC conversion process.
What changed: This document is a limited power of attorney submitted as Exhibits A and B to a Schedule 13G/A filing, executed by Mizuho Financial Group, Inc. and its subsidiaries (Mizuho Bank, Ltd., Mizuho Americas LLC, and Mizuho Securities USA LLC) to authorize Takahiro Katsura, Managing Director, to execute and file Form 13G amendments with the SEC on their behalf. The filing reports no changes to RIBB’s redemption deadline of 2027-01-16, trust share value, extension arrangements, deal progress, or sponsor conduct. As stated by signatory Hidekatsu Take, Deputy President & Corporate Executive, the filing exists solely to grant full power and authority to "execute on behalf of the undersigned Form 13G... complete and execute any amendments, restatements, supplements, and/or exhibits thereto, and timely file such form with the U.S. Securities and Exchange Commission." Why it matters: The document matters only as a routine administrative exhibit enabling Mizuho’s entities to satisfy Section 13(d) and Section 13(g) reporting obligations under the Exchange Act, carrying no mechanical impact on RIBB’s SPAC status, trust preservation, or merger timeline. Beyond cataloging the principal business office addresses for Mizuho Bank, Ltd. (1-5-5, Otemachi, Chiyoda-ku, Tokyo 100020, Japan) and Mizuho Americas LLC/Mizuho Securities USA LLC (1271 Avenue of the Americas, NY, NY 100020, USA) and listing the executive titles of signatories Hidekatsu Take, Managing Executive Officer, Head of Global Corporate & Investment Banking Division, and Adam Hopkins, Chief Legal Officer and Managing Director, General Counsel, the document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel adjustments.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.